amivantamab,lazertinib
janssen,yuhan corp
['biomarker', 'friends', 'amivantamab', 'lazertinib', 'lcsm,(-blcsm)', 'chrysalis-2']
great discussion by dr. carlos g. m. ferreira covering egfr-tkis plus cytotoxic chemotherapy (jcog1404/wjog8214l) and biomarker analysis of chrysalis-2 (amivantamab plus lazertinib). "new friends are silver, old friends are gold" by joseph parry. #asco23 #lcsm 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC